Evidence map›Paper›PMID 38982372›Full record

ArticleBMC microbiology2024

Green synthesis of zinc oxide nanoparticles (ZnO-NPs) by Streptomyces baarnensis and its active metabolite (Ka): a promising combination against multidrug-resistant ESKAPE pathogens and cytotoxicity.

Mohamed H Kalaba, Gamal M El-Sherbiny, Emad A Ewais, Osama M Darwesh, Saad A Moghannem

Abstract read
In one paragraph

Article in BMC microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Unlocking the Hidden Potential ofInternational journal of molecular sciences · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Biogenic copper and copper oxide nanoparticles to combat multidrug-resistantBiotechnology reports (Amsterdam, Netherlands) · 2025
    Review
  16. Article
  17. Article
  18. Article
  19. Molecular detection ofIn silico pharmacology · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mohamed H KalabaBotany and Microbiology Department, Faculty of Science (Boys), Al-Azhar University, Nasr City, Cairo, 11884, Egypt.
Gamal M El-SherbinyBotany and Microbiology Department, Faculty of Science (Boys), Al-Azhar University, Nasr City, Cairo, 11884, Egypt. gamalelsherbiny1970@azhar.edu.eg.
Emad A EwaisBotany and Microbiology Department, Faculty of Science (Boys), Al-Azhar University, Nasr City, Cairo, 11884, Egypt.
Osama M DarweshAgricultural Microbiology Department, National Research Centre, Dokki, Cairo, Egypt.
Saad A MoghannemBotany and Microbiology Department, Faculty of Science (Boys), Al-Azhar University, Nasr City, Cairo, 11884, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Various eco-friendly techniques are being researched for synthesizing ZnO-NPs, known for their bioactivity. This study aimed at biosynthesizing ZnO-NPs using Streptomyces baarnensis MH-133, characterizing their physicochemical properties, investigating antibacterial activity, and enhancement of their efficacy by combining them with a water-insoluble active compound (Ka) in a nanoemulsion form. Ka is a pure compound of 9-Ethyl-1,4,6,9,10-pentahydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione obtained previously from our strain of Streptomyces baarnensis MH-133. Biosynthesized ZnO-NPs employing Streptomyces baarnensis MH-133 filtrate and zinc sulfate (ZnSO

Indexed as

Anti-Bacterial AgentsGreen Chemistry TechnologyMicrobial Sensitivity TestsStreptomycesZinc OxideDrug Resistance, Multiple, BacterialHumansKlebsiella pneumoniaeMetal NanoparticlesMethicillin-Resistant Staphylococcus aureusNanoparticlesAnti-Bacterial AgentsZinc OxideAntibacterial activityBiosynthesisCharacterizationCytotoxicityNanoemulsionZnO-NPs

Identifiers

PMID38982372
PMCPMC11232237

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.